Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia

By |2016-01-23T17:51:42-08:00January 23rd, 2016|We Know Psychiatry|

Abstract Many studies indicate a crucial role for the vitamin B12 and folate-dependent enzyme methionine synthase (MS) in brain development and function, but vitamin B12 status in the brain across the lifespan has not been previously investigated. Vitamin B12 (cobalamin, Cbl) exists in multiple forms, including methylcobalamin (MeCbl) and adenosylcobalamin [...]

Rexulti now in pharmacies, a new treatment for schizophrenia and MDD

By |2015-12-01T16:37:50-08:00December 1st, 2015|MedWorks, We Know Psychiatry|

Rexulti: New treatment for schizophrenia and major depressive disorder approved and released by FDA On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). [...]

T.E.N Vol. 2 No. 2 – Jack Gorman’s Schizophrenia Endowment

By |2015-11-24T21:01:41-08:00November 24th, 2015|MedWorks|

SPECIFIC ARTICLES AVAILABLE FOR DOWNLOAD AND BULK REPRINT FOR ANY QUESTIONS PLEASE CONTACT THE PUBLISHER - ceo@medworksmedia.com T.E.N Vol. 2 No. 2 - Jack Gorman’s Schizophrenia Endowment IN THIS ISSUE: 5 - Journal Mission/Objectives and Guide to Talking Points 7 - Cover Essay: Jack Gorman 15 - Letter from the [...]

Title

Go to Top